Mexonup (Sildenafil)

Sildenafil works by selectively inhibiting the enzyme phosphodiesterase type 5 (PDE5). This inhibition prevents the breakdown of cyclic guanosine monophosphate (cGMP), leading to smooth‑muscle relaxation in the corpus cavernosum and pulmonary vessels, thereby increasing blood flow to the target tissues.

The appropriate dose of Mexonup is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the dosage instructions provided by their healthcare professional and not adjust the dose on their own.

Safety of sildenafil during pregnancy or lactation has not been established. It is generally contraindicated in pregnant women and not recommended for nursing mothers because potential risks to the fetus or infant cannot be ruled out.

To order Mexonup, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

The primary alternative to sildenafil is tadalafil, another PDE5 inhibitor. Both improve erectile function, but tadalafil has a longer half‑life, allowing once‑daily dosing for some patients, whereas sildenafil typically requires dosing on demand. Their safety profiles are similar, though individual tolerability may differ.

Mexonup should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Mexonup is taken orally, usually with a glass of water. It may be taken with or without food, as directed by the prescriber. The timing relative to sexual activity or activity level for pulmonary hypertension should follow the clinician’s guidance.

Serious adverse events associated with sildenafil include priapism (a prolonged erection lasting more than four hours), sudden hearing loss, severe hypotension, myocardial infarction, and stroke. If any of these occur, seek immediate medical attention.

Individuals using nitrates, those with severe uncontrolled hypertension, recent myocardial infarction or stroke, significant cardiovascular disease, or known hypersensitivity to sildenafil should avoid Mexonup. A thorough medical assessment is essential before initiating therapy.